Effect of pangenotype treatment on chronic hepatitis C. Real life studio

Effect of pangenotype treatment on chronic hepatitis C. Real life studio

Bibliographic Details
Main Authors:	I. Santana Salgado, A. Bautista-Santos, R. Moreno Alcántar
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268120301344

Similar Items

Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection in Taiwan
by: Kao-Chi Chang, et al.
Published: (2021-06-01)

Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis
by: Michael J. Zoratti, et al.
Published: (2020-01-01)

Drug–Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study
by: Alessandra Mangia, et al.
Published: (2021-07-01)

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
by: A. Maughan, et al.
Published: (2019-05-01)

Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: A retrospective observational study
by: Afdhal, N.H, et al.
Published: (2021)

Treatment of viral hepatitis C genotypes 1 and 2 by sofosbuvir and ledipasvir with or without ribavirin combination: A possible alternative to pangenotypic treatment in a low-income country?
by: Chantelli Iamblaudiot Razafindrazoto, et al.
Published: (2021-06-01)

Treatment of hepatitis C before and after liver transplantation
by: Rosalba Moreno Alcantar
Published: (2006-01-01)

Evaluation of atherosclerotic risk in patients with chronic hepatitis C infection
by: J.G. Solís, et al.
Published: (2020-09-01)

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics
by: Dorota Zarębska-Michaluk, et al.
Published: (2021-07-01)

Real-Life Experiences with Telaprevir in the Treatment of Chronic Genotype 1 Hepatitis C — The TEPS Study
by: T. Berg, et al.
Published: (2019-01-01)

Quality of life and adherence to treatment of patients with chronic viral hepatitis C
by: R. S. Mirkhaydarov, et al.
Published: (2018-04-01)

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study.
by: Olav Dalgard, et al.
Published: (2017-01-01)

Analogs in the treatment of chronic hepatitis B: real life experience with tenofovir and entecavir
by: Rosanna Villani, et al.
Published: (2015-06-01)

Clinical effect of elbasvir/grazoprevir in treatment of chronic hepatitis C in the real world
by: LIU Fang
Published: (2020-10-01)

Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study
by: Heidar Sharafi, et al.
Published: (2020-01-01)

Chronic hepatitis B treatment guidelines and real-life facts accompanied with six cases
by: E. Guclu, et al.
Published: (2014-04-01)

P62 High SVR rates with eight and twelve weeks of pangenotypic glecaprevir/pibrentasvir: integrated efficacy and safety analysis of genotype 1–6 patients without cirrhosis
by: Massimo Puoti, et al.
Published: (2017-08-01)

All-oral direct antiviral treatment for hepatitis C chronic infection in a real-life cohort: The role of cirrhosis and comorbidities in treatment response.
by: Noelle Miotto, et al.
Published: (2018-01-01)

Quality of life in patients with chronic hepatitis C
by: Pavić Slađana, et al.
Published: (2011-01-01)

Treatment Response of Chronic Hepatitis C Patients and Health-Related Quality of Life
by: Doaa Mohamed, et al.
Published: (2016-06-01)

Emerging treatments for chronic hepatitis C
by: C. Nelson Hayes, et al.
Published: (2015-03-01)

Chronic hepatitis C: future treatment
by: Wendt A, et al.
Published: (2014-01-01)

New drugs in the treatment of chronic hepatitis C
by: R. Jimenez Galan, et al.
Published: (2014-04-01)

Evaluation of life quality of patients with chronic hepatitis C.
by: O. P. Schevchenko-Makarenko, et al.
Published: (2017-12-01)

Peginterferon Treatment In Children: A Review Of Chronic Hepatitis B And Chronic Hepatitis C Treatment
by: Makbule EREN
Published: (2009-11-01)

Early Experience of Sofosbuvir based Combination Therapy in “Real-Life” Cohort with Chronic Hepatitis-C Infection
by: Rajiv Mehta, et al.
Published: (2017-03-01)

Real-life results of sofosbuvir based therapy in chronic hepatitis C -naïve and -experienced patients in Egypt.
by: Ahmed Nagaty, et al.
Published: (2017-01-01)

Current treatment of choice for chronic hepatitis C infection
by: Tareq Yasin, et al.
Published: (2011-01-01)

Treatment of chronic hepatitis C in treatment-naïve patients
by: Marcelo Simão Ferreira

Treatment of chronic hepatitis C in treatment-naïve patients
by: Isaac Quintero Samudio
Published: (2006-01-01)

Quality of life of young patients with chronic hepatitis C
by: D. A. Lioznov, et al.
Published: (2014-09-01)

Health-Related Quality of Life in Chronic Hepatitis C
by: Helder Cardoso, et al.
Published: (2017-01-01)

Entecavir for the treatment of real-life chronic hepatitis B patients: a study from Saudi Arabia
by: Hamad Ibrahim Al-Ashqar, et al.
Published: (2013-03-01)

Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.
by: Karin Neukam, et al.
Published: (2015-01-01)

Focus on the treatment of chronic hepatitis C in children
by: NAN Yuemin
Published: (2018-02-01)

Treatment approach in chronic hepatitis C infection
by: Suheyla Komur, et al.
Published: (2016-06-01)

Predictors of response to chronic hepatitis C treatment
by: Henrique Sergio Moraes Coelho, et al.
Published: (2010-01-01)

Silybin/Silymarin treatment in chronic hepatitis C
by: Varenka J. Barbero-Becerra, et al.
Published: (2012-09-01)

Chronic hepatitis C treatment in näive patients
by: Jorge Daruich
Published: (2010-01-01)

Effectiveness and safety of narlaprevir in real clinical practice of chronic hepatitis C
by: V. V. Basina, et al.
Published: (2019-12-01)